Literature DB >> 14593193

Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis.

Mitsuaki Tatsumi1, Christian Cohade, Yuji Nakamoto, Richard L Wahl.   

Abstract

PURPOSE: To evaluate fluorine 18 fluorodeoxyglucose (FDG) uptake in the thoracic aortic wall at combined positron emission tomography (PET)/computed tomography (CT) and compare uptake with aortic wall calcification.
MATERIALS AND METHODS: Records of 85 consecutive cancer patients who underwent FDG PET/CT were evaluated retrospectively. One hour after FDG injection, CT followed by PET was performed from ear to middle of the thigh. CT, PET, and fused PET/CT images were generated. FDG uptake and calcification were evaluated visually and semiquantitatively. FDG uptake was graded according to intensity; calcification, according to thickness. Unpaired t test was used for comparison of patient age with and without FDG uptake and with and without calcification. The relationship between the score (sum of grades along all aortic segments) of positive FDG uptake and calcification and patient age was analyzed with Spearman rank correlation. Comparison of frequency of FDG uptake and calcification with age, sex, risk factors for cardiovascular disease (CVD), or history of CVD was performed with chi2 analysis.
RESULTS: Fifty patients had at least one area of FDG uptake in thoracic aortic wall, 14 of whom showed focal FDG uptake. Intermediate to intense FDG uptake tended to be observed in the descending aorta. Forty-five patients had at least one measurable aortic calcification. Thick calcification was observed most often at the aortic arch. Twelve patients had 13 uptake areas at the calcification site. Patients with positive findings were on average older (P <.05 for both increased uptake and calcification); the older patient group had higher frequency of both aortic wall uptake (P <.005) and calcification (P <.001). The calcification score correlated with age (rho = 0.60, P <.001) but the FDG uptake score did not. Women, patients with hyperlipidemia, and patients with history of CVD tended to show increased FDG uptake (P =.073,.080, and.068, respectively), whereas patients with diabetes had significantly more calcifications (P <.05).
CONCLUSION: PET/CT depicted FDG uptake commonly in the thoracic aortic wall. The FDG uptake site was mostly distinct from the calcification site and may possibly be located in areas of metabolic activity of atherosclerotic changes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593193     DOI: 10.1148/radiol.2293021168

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  62 in total

1.  Uptake of F-18 FDG and ultrasound analysis of carotid plaque.

Authors:  Yun-Seok Choi; Ho-Joong Youn; Woo-Baek Chung; Hui-Jeong Hwang; Dong-Hyeon Lee; Chul-Soo Park; Jae-Beom Lee; Pum-Joon Kim; Wook-Sung Chung; Man-Young Lee; Kie-Bae Seung; Yong-Ahn Chung
Journal:  J Nucl Cardiol       Date:  2011-01-29       Impact factor: 5.952

Review 2.  Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.

Authors:  Ian S Rogers; Ahmed Tawakol
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

3.  Imaging of unstable atherosclerotic lesions.

Authors:  Jagat Narula; H William Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-01       Impact factor: 9.236

4.  (18)F-fluorodeoxyglucose PET imaging of coronary atherosclerosis and plaque inflammation.

Authors:  Wengen Chen; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

Review 5.  Targeting the vulnerable plaque: the evolving role of nuclear imaging.

Authors:  John R Davies; James F Rudd; Tim D Fryer; Peter L Weissberg
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

6.  The atherosclerotic plaque: a healthy challenge to the limits of nuclear imaging.

Authors:  Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

7.  Identification of interleukin-2 for imaging atherosclerotic inflammation.

Authors:  Zahi A Fayad; Vardan Amirbekian; Jean-François Toussaint; Valentin Fuster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02       Impact factor: 9.236

Review 8.  [Advances in cardiovascular medicine through molecular imaging].

Authors:  M Nahrendorf; R Weissleder
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

9.  Atheroma roulette.

Authors:  H William Strauss; Jagat Narula
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

10.  Atherosclerotic plaque imaging by PET/CT; can inactive, active and mixed plaques be discerned?

Authors:  E E van der Wall; J D Schuijf; J W Jukema; J J Bax; A van der Laarse
Journal:  Int J Cardiovasc Imaging       Date:  2008-12-05       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.